Executed Additional Statement of Work Worth
$1.5M
MONTREAL, July 13,
2022 /CNW Telbec/ - Carebook Technologies Inc.
("Carebook" or the "Company") (TSXV: CRBK) (OTCPK:
CRBKF) (XFRA: PMM1), a leading Canadian provider of innovative
digital health solutions is pleased to announce a significant
addition under its pharmacy solution agreement with its major
pharmacy client. The additional statement of work ("SOW")
expanding the scope under the agreement was signed on June 29th and is worth an incremental
$1.5 million over a one-year term,
representing an increase of over 83% in pharmacy contract value for
Carebook.
Carebook has completed the expansion of its existing team for
the solution, nearly doubling capacity to deliver on the continued
development of its robust, customer-facing platform. The pharmacy
solution pertaining to the SOW is governed by a master agreement,
filed on SEDAR at www.sedar.com on October
23rd, 2020.
"We are very proud of what we have accomplished since the
original signing of the master service agreement and the value we
have created for our client." commented Michael Peters, Carebook CEO. "This new
statement of work is a clear affirmation of the strong relationship
we have built with our cornerstone client in the pharmacy market
and the success of our leading digital solution. We will continue
to strive to build meaningful solutions for the pharmacy market
that connect customers to their pharmacy in new and exciting
ways."
About Carebook
Technologies
Carebook's digital health platform empowers its clients and more
than 3.5 million members to take control of their health journey.
During 2021, the Company completed the acquisitions of InfoTech
Inc., a global leader in health and productivity risk management,
and CoreHealth Technologies Inc., owner of an industry-leading
wellness platform. In combination, these companies create a
comprehensive digital health platform that includes both assessment
tools and the technology to deliver complementary solutions.
Carebook's shares trade on the TSXV under the symbol "CRBK," on the
OTC Markets under the symbol "CRBKF," and are listed on the Open
Market of the Frankfurt Stock Exchange under the symbol "PMM1."
www.carebook.com
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
Notice regarding forward-looking
statements:
This release includes forward-looking information and
forward-looking statements within the meaning of Canadian
securities laws regarding Carebook, its subsidiaries and their
business. Often, but not always, forward-looking information can be
identified by the use of words such as "plans", "is expected",
"expects", "scheduled", "intends", "contemplates", "anticipates",
"believes", "proposes" or variations (including negative
variations) of such words and phrases, or state that certain
actions, events or results "may", "could", "would", "might" or
"will" be taken, occur or be achieved. Forward-looking information
in this release include statements with respect to the development
of the Company's products for the pharmacy segment. Such statements
are based on the current expectations of the management of Carebook
and are based on assumptions and subject to risks and
uncertainties. Although the management of Carebook believes that
the assumptions underlying these statements are reasonable, they
may prove to be incorrect, and undue reliance should not be placed
on such forward-looking statements. The forward-looking statements
reflect the Company's current views with respect to future events
based on currently available information and are inherently subject
to risks and uncertainties. The forward-looking events and
circumstances discussed in this release may not occur by certain
specified dates or at all and could differ materially as a result
of known and unknown risk factors and uncertainties affecting the
Company, including economic factors, management's ability to manage
and to operate the business of Carebook, management's ability to
successfully integrate the Company's completed acquisitions and to
realize the synergies of such acquisitions, management's ability to
successfully complete product studies, the equity markets generally
and risks associated with growth and competition, as well as the
risk factors identified in the Company's management's discussion
and analysis for the year ended December 31,
2021 and described under the heading "Item 21 – Risk
Factors" in the Listing Application of the Company dated
September 28, 2020, each of which can
be found on SEDAR under the Company's profile at
www.sedar.com. Although Carebook has attempted to
identify important factors that could cause actual actions, events
or results to differ materially from those described in
forward-looking statements, there may be other factors that cause
actions, events or results to differ from those anticipated,
estimated or intended. Accordingly, readers should not place undue
reliance on any forward-looking statements or information. No
forward-looking statement can be guaranteed. Except as required by
applicable securities laws, forward-looking statements speak only
as of the date on which they are made and Carebook does not
undertake any obligation to publicly update or revise any
forward-looking statement, whether as a result of new information,
future events, or otherwise. In addition, the current situation and
future developments with respect to the COVID-19 pandemic could
cause certain of the assumptions and information set forth herein
or the fact that on which such assumptions are based to differ
materially from previous expectations including in respect of
demand for our products, access to debt and equity capital and
other factors.
SOURCE Carebook Technologies Inc.